what-we-do cro-centered-services 
Worldwide Clinical Trials
FEBRUARY 22, 2023
Panelists will answer questions such as: What are the greatest challenges holding patients back from enrolling in trials? What will have the greatest impact on rare disease patients in 2023? What does our industry still need to consider in order to create more accessible treatments? So, I decided to pivot.
XTalks
OCTOBER 18, 2022
A clinical research organization (CRO) is a company that delivers outsourced services to plan, manage and execute clinical trials for biotechnology, pharmaceutical, and medical device companies. Why Should One Consider Working for a CRO? Out of that $70 billion, clinical-related services account for 40 to 60 percent.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
JUNE 10, 2020
And you know, we try and get a pulse on anything that’s going on that will impact our clients, obviously. And I’ll say, you know, it’s been very interesting over the last four years of following this, that we’re now seeing more and more the innovations really starting to hit the enterprise.
XTalks
MAY 6, 2022
In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Lacroix is responsible for leading the data management function at eClinical Solutions.
XTalks
AUGUST 4, 2022
“If you do not have a plan to drive enrollment for 40 percent of the US population who identify as racial or ethnic minorities, you are already starting with the glass half full. If you want to do a hypertension or hyperlipidemia trial where the enrollment ranges 18 to 80, age distribution by race might not matter as much.
Pharma Marketing Network
JUNE 10, 2020
And you know, we try and get a pulse on anything that’s going on that will impact our clients, obviously. And I’ll say, you know, it’s been very interesting over the last four years of following this, that we’re now seeing more and more the innovations really starting to hit the enterprise.
WCG Clinical
MAY 24, 2023
Information from the Tufts Center for the Study of Drug Development and WCG’s Knowledge Base, reveal that 37% of sites selected for clinical trial studies under-enroll compared to their original forecast. And, as we all know, roughly 11% of sites fail to enroll a single participant in a trial. Why do we frequently fail at feasibility?
Expert insights. Personalized for you.
130 
Let's personalize your content